Spotlight -

Drug Development|

Quality Systems

Karl Ennis

Articles by Karl Ennis

Import Testing of Pharmaceutical Products Has Limited Safety Benefits and Can Add Risk to Patients

ByStephan Rönninger,Karl Ennis,Joerg H.O. Garbe,Guido M. Furer,Maria G. Jacobs

August 2nd 2015

Latest Updated Articles

Import Testing of Pharmaceutical Products Has Limited Safety Benefits and Can Add Risk to Patients
August 2nd 2015

Trending on Pharmaceutical Technology

How AI Can Assist with Post-Marketing Changes

What Does Overton's FDA Nomination Mean for Drug Reviews?

Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models

Ecopipam's D1 Receptor Approach Signals New Pediatric Neuroscience Pathway

GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing